We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Large-Scale Trial Shows Lunit Breast Cancer AI More Accurate than Radiologist Reviews
Large-Scale Trial Shows Lunit Breast Cancer AI More Accurate than Radiologist Reviews
Lunit’s study of 55,579 mammograms showed an increased cancer detection rate and a lower patient recall rate using the company’s Insight MMG breast cancer artificial (AI) solution than a team of two radiologists, the South Korea-headquartered company reported.